Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Albuterol Spiromax in Asthma
NCT01218009Phase 3Terminated
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Oct 2010
- Primary completion
- Dec 2010
- Countries
- 1
01
Overview
A Phase 3 trial of albuterol dry powder inhaler in asthma, sponsored by Teva Pharmaceutical Industries Ltd.. Started Oct 2010; status: terminated.
02
Drugs
albuterol dry powder inhaler
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01218009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01218009.